Tiblio
Sign Up

HLN

Haleon plc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$42.09B
P/E Ratio
18.94
EPS
$0.50
Beta
0.33
52W High
$11.20
52W Low
$8.60
50-Day MA
$10.15
200-Day MA
$9.81
Dividend Yield
0.75%
Profit Margin
15.10%
Forward P/E
17.79
PEG Ratio
2.47

About Haleon plc

Haleon plc (HLN) is a prominent global player in the consumer health sector, dedicated to providing innovative health solutions through its diverse portfolio, which includes renowned brands like Sensodyne, Panadol, and Voltaren. Established as a spin-off from GlaxoSmithKline, the company leverages its strong brand equity to cater to critical health segments such as oral care, pain relief, and dietary supplements. Committed to sustainability and consumer-centric innovation, Haleon is strategically positioned to enhance health outcomes worldwide while pursuing growth and generating value for its shareholders through targeted investments and continuous product development.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$11.03B
Gross Profit (TTM)$7.14B
EBITDA$2.74B
Operating Margin23.20%
Return on Equity10.30%
Return on Assets4.67%
Revenue/Share (TTM)$2.46
Book Value$4.98
Price-to-Book1.90
Price-to-Sales (TTM)3.82
EV/Revenue3.487
EV/EBITDA13.45
Quarterly Earnings Growth (YoY)92.00%
Quarterly Revenue Growth (YoY)0.60%
Shares Outstanding$4.44B
Float$8.86B
% Insiders0.01%
% Institutions12.76%

Historical Volatility

HV 10-Day
21.00%
HV 20-Day
15.86%
HV 30-Day
18.39%
HV 60-Day
25.36%
HV Rank
15.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($11.81 target)
2
Strong Buy
1
Buy
1
Hold
Data last updated: 4/29/2026